Absorbent products for incontinence: 'treatment effects' and impact on quality of life.

Absorbent products for incontinence: 'treatment effects' and impact on quality of life. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Absorbent products for incontinence: 'treatment effects' and impact on quality of life. Abstract Text:

Kathryn Getliffe,Mandy Fader,Alan Cottenden,Katharine Jamieson,Nicholas Green,

AIM: This study aimed to determine how the use and characteristics of absorbent products for incontinence impact on women's quality of life, and to examine the concept of 'treatment effects' in the context of pad use. METHOD: Key pad performance characteristics were identified from the literature and focus group work. Semi-structured interviews with 99 women with light incontinence were used to investigate the impact of pad use on women's quality of life, including both positive and negative 'treatment effects', and to rank pad characteristics by their importance. RESULTS: Achieving effective and discrete containment of urine was the dominant factor impacting on women's lives. Sub-themes embraced physical effects, psychological impact and social functioning. The five pad characteristics ranked most important for day time use were: 'to hold urine, to contain smell, to stay in place, discreteness, and comfort when wet. For night use discreteness was replaced by to keep skin dry'. High levels of reported anxiety were associated with perceived risk of poor pad performance, lack of discreteness and need for complex regimes for pad management. CONCLUSION: Insufficient attention has been paid to the balance between the beneficial and negative treatment effects of absorbent pads to date. Existing continence-related quality of life measures are not designed for conditions where change in symptoms is not an outcome measure. The study findings provide the basis for developing a more sensitive, patient-oriented, quality of life measure for pad-users which can aid product selection, new product development and inform future evaluative comparisons between products/products and treatments. RELEVANCE TO CLINICAL PRACTICE: This paper illustrates the complex influence on quality of life caused by using absorbent pads to contain incontinence. It raises awareness of the importance of careful selection of the most appropriate pad for each individual to minimize unfavourable side effects, and the need for a new quality of life measure designed for pad-users.

Absorbent products for incontinence: 'treatment effects' and impact on quality of life. Publishing Authors By Initials

K Getliffe,M Fader,A Cottenden,K Jamieson,N Green,

For similar persons: women research abstracts see: persons: women research

PUBMED ID PMID:

MEDLINE DATE:

Absorbent products for incontinence: 'treatment effects' and impact on quality of life. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Journal of clinical nursing

VOLUME: 16

Page Numbers: 1936-45

Journal Abbreviation:

ISSN: 0962-1067

DAY: 29

MONTH: Oct

YEAR: 2007

Absorbent products for incontinence: 'treatment effects' and impact on quality of life. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9207302

Absorbent products for incontinence: 'treatment effects' and impact on quality of life. Keywords Mesh Terms:

KEYWORDS: Women

MESH TERMS: psychology

Chemical & Substance for Abstract: Absorbent products for incontinence: 'treatment effects' and impact on quality of life. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Absorbent products for incontinence: 'treatment effects' and impact on quality of life.

AFFILIATION: School of Nursing and Midwifery, University of Southampton, Highfield, Southampton, UK. k.a.getliffe@soton.ac.uk

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Clin Nurs

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Absorbent products for incontinence: 'treatment effects' and impact on quality of life Related Publications

• A comparison of multi-layer neural network and logistic regression in hereditary non-polyposis colorectal cancer risk assessment.
• After 30 years ... the future of hydroxyacids.
• An analysis of categorical perception of facial emotion in schizophrenia.
• Antifertility effect of busulfan and DL-6-(N-2-pipecolinomethyl)-5-hydroxy-indane maleate (PMHI) in coyotes (Canis Latrans ).
• Apoptosis of epitope-specific antiretroviral cytotoxic T lymphocytes via Fas ligand-Fas interactions.
• Buccal cells as biomarkers of fat intake.
• Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders.
• Coordinative organization of lingual propulsion during the normal adult swallow.
• Corneal endothelial injury thresholds for exposures to 1.54 micro m radiation.
• Disorders of extreme stress (DESNOS) symptoms are associated with type and severity of interpersonal trauma exposure in a sample of healthy young women.
• Effects of adrenalectomy on serum concentrations of progesterone during the luteal phase of sheep.
• Emergency department access to a longitudinal medical record.
• Exploring the short term visual store in schizophrenia using the attentional blink.
• Fas-mediated apoptosis and sphingomyelinase signal transduction: the role of ceramide as a second messenger for apoptosis.
• Future randomized trials for non small-cell lung cancer.
• Genetic manipulation of circadian rhythms in Xenopus.
• Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression.
• Inhibition of ceramide-induced apoptosis by Bcl-2.
• LC-MS analysis of carbonyl compounds and their occurrence in diesel emissions.
• Lingual heat and cold sensitivity following exposure to capsaicin or menthol.
• Molecular cloning and developmental expression of Par-1/MARK homologues XPar-1A and XPar-1B from Xenopus laevis.
• Pathology of immunodeficient mice with naturally occurring murine norovirus infection.
• Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902.
• Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis.
• Structure/function analysis of Xenopus cryptochromes 1 and 2 reveals differential nuclear localization mechanisms and functional domains important for interaction with and repression of CLOCK-BMAL1.
• The abl oncogene family and apoptosis.
• The effects of the ARC organizational intervention on caseworker turnover, climate, and culture in children's service systems.
• The psychophysical relationship between bitter taste and burning sensation: evidence of qualitative similarity.
• Tissue remodeling during maturation of the Drosophila wing.
• Toxicology and drug testing in aviation.